<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00736684</url>
  </required_header>
  <id_info>
    <org_study_id>PROGAINT-ES-08</org_study_id>
    <nct_id>NCT00736684</nct_id>
  </id_info>
  <brief_title>Proximal Femoral Nail Antirotation™ (PFNA) Versus Gamma Nail 3™ (Gamma3) for Intramedullary Nailing of Unstable Trochanteric Fractures</brief_title>
  <acronym>PROGAINT-ES</acronym>
  <official_title>Proximal Femoral Nail Antirotation™ (PFNA) Versus Gamma Nail 3™ (Gamma3) for Intramedullary Nailing of Unstable Trochanteric Fractures - a Multicenter Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AO Clinical Investigation and Documentation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Synthes Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>AO Clinical Investigation and Documentation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare rates of any fracture fixation complication and
      revision rates after intramedullary fixation of unstable trochanteric fractures between the
      Proximal Femoral Nail Antirotation™ (PFNA)(Investigational Group) and Gamma Nail 3™ (Gamma3)
      (Control Group).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intramedullary nailing of unstable per- and subtrochanteric femoral fractures is a standard
      procedure in trauma and orthopaedic surgery. Unstable fractures treated with intramedullary
      nailing carry the risk of fracture fixation complications. The PFNA (Synthes) has evolved
      from the original PFN design, featuring a novel antirotation screw. Apart from the prevention
      of excess rotational forces, this supporting element may enhance the overall stability of the
      construct, thus potentially reducing fracture fixation complications. Empirical information
      about the fracture fixation complication rates of the PFNA device is not available. The
      primary objective of this study is to compare the 1-year fracture fixation rates between the
      PFNA and Gamma Nail 3™ (Stryker). Secondary objectives of the study are to compare
      differences in functional outcomes, quality of life outcomes, safety, radiological outcomes,
      handling and perceived effectiveness between the devices.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Any fracture fixation complication.</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone union/fusion as evaluated by CT-scanning, health-related quality of life, disease-specific functional scoring, activities of daily living, mortality, radiological parameters, surgery details and surgeons' evaluation of handling and effectiveness.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">440</enrollment>
  <condition>Unstable Trochanteric Fractures</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Proximal Femoral Nail AntirotationTM (PFNA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Gamma Nail 3TM (Gamma3)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Proximal Femoral Nail AntirotationTM (PFNA)</intervention_name>
    <description>intramedullary nailing</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Gamma Nail 3TM (Gamma3)</intervention_name>
    <description>intramedullary nailing</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 55 years and more

          -  Patients with isolated, unstable, closed or type 1 open trochanteric fractures,
             classified as AO 31-A2 or AO 31-A3

          -  Definitive primary fracture treatment with PFNA or Gamma3 (defined inTable 1) within
             three days after the index event

          -  Signed written informed consent (by the subjects or legal guardian) and agreement to
             attend the planned follow-ups

        Exclusion Criteria:

          -  Pathologic fracture of any other cause than osteoporosis

          -  Patients or legal guardian refusing to sign the informed consent form

          -  Multiple trauma

          -  Type 2 and 3 open fractures

          -  Drug or alcohol abuse

          -  Wound and/or bone healing disorders of any other cause than diabetes mellitus or
             smoking

          -  Active malignancy

          -  Expected life expectancy ≤ 3 months

          -  Inability to walk independently prior to injury event (use of one stick is allowed.
             Not meeting inclusion criteria are bedridden, wheel-chair ridden and walker dependent
             subjects)

          -  Neurological and psychiatric disorders that would preclude reliable assessment (eg,,
             Parkinson disease, Multiple sclerosis, severe depression)

          -  Rheumatoid arthritis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beate P. Hanson, MD</last_name>
    <role>Study Director</role>
    <affiliation>AO Clinical Investigation and Documentation, Davos, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Javier Vaquero Martin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Gregorio Marañon, Madrid, Spain</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario &quot;Marqués de Valdecilla&quot;</name>
      <address>
        <city>Santander</city>
        <state>Cantabria</state>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <state>Cataluña</state>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Gregorio Marañon</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Puerta de Hierro</name>
      <address>
        <city>Madrid</city>
        <zip>28035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H.U. Virgen de la Arrixaca</name>
      <address>
        <city>Murcia</city>
        <zip>30071</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Donostia</name>
      <address>
        <city>San Sebastián</city>
        <zip>20014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2008</study_first_submitted>
  <study_first_submitted_qc>August 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2008</study_first_posted>
  <last_update_submitted>February 10, 2011</last_update_submitted>
  <last_update_submitted_qc>February 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Javier Vaquero Martin, MD</name_title>
    <organization>Hospital Gregorio Marañon</organization>
  </responsible_party>
  <keyword>Femoral fractures [MeSH]</keyword>
  <keyword>hip fractures [MeSH]</keyword>
  <keyword>trochanteric fractures (femoral neck fractures [MeSH])</keyword>
  <keyword>intramedullary nailing (fracture fixation, intramedullary [MeSH])</keyword>
  <keyword>complex femoral fractures</keyword>
  <keyword>femoral nail</keyword>
  <keyword>surgical treatment (surgical procedures, operative [MeSH])</keyword>
  <keyword>complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

